Back to Newslist August 04 | 2019

Vectron's dual UTR technology has been granted patent protection by the European Patent Office.

This technology allows the design of synthetic 5'-UTR sequences for maximized transcription and translation, individually. A common problem when optimizing 5'-UTRs for elevated expression of recombinant proteins is that an increase in transcription negatively affects translation, and vice versa. By using the dual UTR technology, Vectron can optimize both transcription and translation irrespective of each other and as a result achieve much higher and predictable expression rates.